INTELLIPHARMACEUTICS INTERNATIONAL INC. Operating Income
INTELLIPHARMACEUTICS INTERNATIONAL INC. reported Operating Income of -$1.79 million for the 3-month period ending 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-02-06
- INTELLIPHARMACEUTICS INTERNATIONAL INC. operating income (loss) for the quarter ending 2017-05-31 was -1.75M CAD.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. operating income (loss) for the quarter ending 2017-02-28 was -1.85M CAD.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. operating income (loss) for the quarter ending 2016-05-31 was -1.91M CAD.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. operating income (loss) for the quarter ending 2016-02-29 was -2.09M CAD.
CAD
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 12 month |
|---|---|---|---|
| 2018-11-30 | -13.33M CAD 20-F · filed 2019-03-04 | ||
| 2017-11-30 | -8.27M CAD 20-F · filed 2019-03-04 | ||
| 2017-05-31 | -1.75M CAD 6-K · filed 2017-07-11 | -3.60M CAD 6-K · filed 2017-07-11 | |
| 2017-02-28 | -1.85M CAD 6-K · filed 2017-04-12 | ||
| 2016-11-30 | -9.85M CAD 20-F · filed 2019-03-04 | ||
| 2016-05-31 | -1.91M CAD 6-K · filed 2017-07-11 | -4.00M CAD 6-K · filed 2017-07-11 | |
| 2016-02-29 | -2.09M CAD 6-K · filed 2017-04-12 | ||
| 2015-11-30 | -7.11M CAD 20-F · filed 2018-03-01 | ||
| 2014-11-30 | -3.53M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-08-31 | -$1.79M 6-K · filed 2023-10-16 | -$1.82M derived: sum of 2 quarters · filed 2023-10-16 | -$2.12M 6-K · filed 2023-10-16 | -$2.58M derived: sum of 4 quarters · filed 2024-02-06 |
| 2023-05-31 | -$31.36K 6-K · filed 2023-09-26 | -$332.75K 6-K · filed 2023-09-26 | -$792.33K derived: sum of 3 quarters · filed 2024-02-06 | -$1.16M derived: sum of 4 quarters · filed 2024-02-06 |
| 2023-02-28 | -$301.40K 6-K · filed 2023-09-26 | -$760.98K derived: sum of 2 quarters · filed 2024-02-06 | -$1.13M derived: sum of 3 quarters · filed 2024-02-06 | -$2.38M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-11-30 | -$459.58K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | -$825.76K derived: sum of 2 quarters · filed 2024-02-06 | -$2.08M derived: sum of 3 quarters · filed 2024-02-06 | -$2.85M 20-F/A · filed 2024-02-06 |
| 2022-08-31 | -$366.18K 6-K · filed 2023-10-16 | -$1.62M derived: sum of 2 quarters · filed 2023-10-16 | -$2.39M 6-K · filed 2023-10-16 | -$3.79M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-05-31 | -$1.25M 6-K · filed 2023-09-26 | -$2.02M 6-K · filed 2023-09-26 | -$3.42M derived: sum of 3 quarters · filed 2024-02-06 | -$4.51M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-02-28 | -$772.91K 6-K · filed 2023-09-26 | -$2.17M derived: sum of 2 quarters · filed 2024-02-06 | -$3.25M derived: sum of 3 quarters · filed 2024-02-06 | -$4.16M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-11-30 | -$1.40M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | -$2.48M derived: sum of 2 quarters · filed 2024-02-06 | -$3.39M derived: sum of 3 quarters · filed 2024-02-06 | -$4.17M 20-F/A · filed 2024-02-06 |
| 2021-08-31 | -$1.08M 6-K · filed 2022-10-14 | -$1.99M derived: sum of 2 quarters · filed 2022-10-14 | -$2.78M 6-K · filed 2022-10-14 | -$4.24M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-05-31 | -$906.85K 6-K · filed 2022-07-21 | -$1.69M 6-K · filed 2022-07-21 | -$3.15M derived: sum of 3 quarters · filed 2024-02-06 | -$4.28M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-02-28 | -$784.91K 6-K · filed 2022-04-14 | -$2.25M derived: sum of 2 quarters · filed 2024-02-06 | -$3.38M derived: sum of 3 quarters · filed 2024-02-06 | -$4.27M derived: sum of 4 quarters · filed 2024-02-06 |
| 2020-11-30 | -$1.46M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | -$2.59M derived: sum of 2 quarters · filed 2024-02-06 | -$3.48M derived: sum of 3 quarters · filed 2024-02-06 | -$4.68M 20-F/A · filed 2024-02-06 |
| 2020-08-31 | -$1.13M 6-K · filed 2021-10-15 | -$2.02M derived: sum of 2 quarters · filed 2021-10-15 | -$3.22M 6-K · filed 2021-10-15 | -$4.49M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-05-31 | -$890.24K 6-K · filed 2021-07-15 | -$2.09M 6-K · filed 2021-07-15 | -$3.36M derived: sum of 3 quarters · filed 2022-05-09 | -$4.72M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-02-29 | -$1.20M 6-K · filed 2021-04-14 | -$2.47M derived: sum of 2 quarters · filed 2022-05-09 | -$3.83M derived: sum of 3 quarters · filed 2022-05-09 | -$5.88M derived: sum of 4 quarters · filed 2022-05-09 |
| 2019-11-30 | -$1.28M derived: 20-F/A 12 month − 6-K 9 month · filed 2022-05-09 | -$2.64M derived: sum of 2 quarters · filed 2022-05-09 | -$4.68M derived: sum of 3 quarters · filed 2022-05-09 | -$7.83M 20-F/A · filed 2022-05-09 |
| 2019-08-31 | -$1.36M 6-K · filed 2020-10-15 | -$3.40M derived: sum of 2 quarters · filed 2020-10-15 | -$6.56M 6-K · filed 2020-10-15 | -$10.08M derived: sum of 4 quarters · filed 2021-03-31 |
| 2019-05-31 | -$2.04M 6-K · filed 2020-07-15 | -$5.20M 6-K · filed 2020-07-15 | -$8.72M derived: sum of 3 quarters · filed 2021-03-31 | -$12.63M derived: sum of 4 quarters · filed 2021-03-31 |
| 2019-02-28 | -$3.15M 6-K · filed 2020-05-29 | -$6.68M derived: sum of 2 quarters · filed 2021-03-31 | -$10.58M derived: sum of 3 quarters · filed 2021-03-31 | -$13.39M derived: sum of 4 quarters · filed 2021-03-31 |
| 2018-11-30 | -$3.53M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-31 | -$7.43M derived: sum of 2 quarters · filed 2021-03-31 | -$10.24M derived: sum of 3 quarters · filed 2021-03-31 | -$13.33M 20-F · filed 2021-03-31 |
| 2018-08-31 | -$3.90M 6-K · filed 2019-10-11 | -$6.71M derived: sum of 2 quarters · filed 2019-10-11 | -$9.80M 6-K · filed 2019-10-11 | -$12.10M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-05-31 | -$2.81M 6-K · filed 2019-07-10 | -$5.90M 6-K · filed 2019-07-10 | -$8.19M derived: sum of 3 quarters · filed 2020-03-30 | -$10.56M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-02-28 | -$3.09M 6-K · filed 2019-04-15 | -$5.39M derived: sum of 2 quarters · filed 2020-03-30 | -$7.76M derived: sum of 3 quarters · filed 2020-03-30 | -$9.51M derived: sum of 4 quarters · filed 2020-03-30 |
| 2017-11-30 | -$2.30M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | -$4.67M derived: sum of 2 quarters · filed 2020-03-30 | -$6.42M derived: sum of 3 quarters · filed 2020-03-30 | -$8.27M 20-F · filed 2020-03-30 |
| 2017-08-31 | -$2.37M 6-K · filed 2018-10-15 | -$4.12M derived: sum of 2 quarters · filed 2018-10-15 | -$5.97M 6-K · filed 2018-10-15 | |
| 2017-05-31 | -$1.75M 6-K · filed 2018-07-24 | -$3.60M 6-K · filed 2018-07-24 |